Cell Survival Curves — MCQs
Radiation mediates its effect by
Variation in sensitivity of response to different doses of a drug in different individuals is obtained from?
Radiation exposure can lead to which type of thyroid carcinoma?
Which of the following is most radioresistant?
Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
International prognostic index for lymphomas includes the following prognostic factors, EXCEPT:
A 26-year-old male presents to the outpatient department with a discrete thyroid swelling. On neck ultrasound, an isolated cystic swelling of the gland is seen. What is the risk of malignancy associated with this finding?
What is the radiation tolerance of the whole liver?
When is oxygen effective during radiotherapy?
A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following statements about radiation therapy is true?
Cell Survival Curves Indian Medical PG Practice Questions and MCQs
Question 1: Radiation mediates its effect by
- A. Protein coagulation
- B. Osmolysis of cells
- C. Ionization of the molecules (Correct Answer)
- D. Denaturation of DNA
Explanation: ***Ionization of the molecules*** - Radiation, particularly **ionizing radiation**, interacts with biological molecules by ejecting electrons, leading to the formation of highly reactive **ions and free radicals** [1]. - This **ionization** process is the primary mechanism by which radiation damages cellular components, including **DNA** [2]. *Protein coagulation* - While radiation can cause protein damage, **coagulation** is not its primary or direct mechanism, especially at clinically relevant doses. - Protein coagulation is more typically associated with **heat** or certain strong chemical agents. *Osmolysis of cells* - **Osmolysis** refers to the rupture of cells due to excessive water influx, often caused by changes in osmotic pressure. - Radiation does not directly induce **osmotic imbalances** leading to cell lysis. *Denaturation of DNA* - While radiation ultimately leads to **DNA damage**, denaturation (unfolding) is a specific type of damage, often caused by heat or extreme pH. - The direct effect of radiation is **ionization**, which then indirectly causes various forms of DNA damage including breaks, cross-links, and base modifications, but not solely "denaturation" [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 101-102. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 436-437.
Question 2: Variation in sensitivity of response to different doses of a drug in different individuals is obtained from?
- A. Dose-response relationship (Correct Answer)
- B. Therapeutic index
- C. Bioavailability
- D. Phase 1 clinical trials
Explanation: ***Dose-response relationship*** - The **dose-response relationship** (particularly the **graded dose-response curve**) describes how the magnitude of a drug's effect changes with different doses. - When plotted for different individuals or populations, these curves reveal **variation in sensitivity** through differences in potency (horizontal shift) and efficacy (maximum response). - This relationship helps characterize inter-individual variability in drug response and is the fundamental concept for understanding differential sensitivity. *Therapeutic index* - The **therapeutic index** is a measure of drug safety, representing the ratio between the toxic dose and the effective dose (TD50/ED50 or LD50/ED50). - It does not directly explain the variation in sensitivity to different doses among individuals, but rather provides information about the drug's overall safety margin. *Bioavailability* - **Bioavailability** refers to the fraction of an administered drug that reaches the systemic circulation unchanged. - While it influences the drug concentration at the site of action, it doesn't directly measure the variability in physiological response to that concentration among individuals. *Phase 1 clinical trials* - **Phase 1 clinical trials** are the first stage of testing a new drug in humans, primarily focusing on safety, dosage range, and pharmacokinetics in a small group of healthy volunteers. - While variability in response may be observed during these trials, they are not the *pharmacological concept* that describes this variation; rather, dose-response relationships are used to interpret findings from these trials.
Question 3: Radiation exposure can lead to which type of thyroid carcinoma?
- A. Lymphoma
- B. Papillary carcinoma (Correct Answer)
- C. Medullary carcinoma
- D. Follicular carcinoma
Explanation: ***Papillary carcinoma*** - Papillary thyroid carcinoma is strongly associated with **radiation exposure**, particularly during childhood [1]. - It is the most prevalent type of thyroid cancer and typically has a **good prognosis** [1]. *Lymphoma* - Thyroid lymphoma is rare and generally not linked to **radiation exposure**; it often presents as a **rapidly enlarging goiter**. - It is more commonly associated with **autoimmune thyroiditis**, not primary radiation effects. *Follicular carcinoma* - Follicular carcinoma shows a correlation with **iodine deficiency** rather than radiation exposure [1]. - Its presentation is more subtle, compared to the classical association of **radiation with papillary carcinoma**. *Medullary carcinoma* - Medullary thyroid carcinoma is primarily linked to **familial syndromes** like MEN 2 and not radiation exposure. - It arises from **parafollicular C cells**, making it clinically distinct from radiation-related types. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1098-1099.
Question 4: Which of the following is most radioresistant?
- A. Cartilage (Correct Answer)
- B. Ewing's sarcoma
- C. GIT epithelium
- D. Gonadal tumours
Explanation: ***Cartilage*** - **Cartilage** is a connective tissue with a relatively **low metabolic rate** and **avascular nature**, making its cells (chondrocytes) less susceptible to rapid turnover and DNA damage from radiation. - Its **dense extracellular matrix** and limited cellular division contribute to its inherent resistance to ionizing radiation, requiring higher doses to induce significant damage. *Ewing's sarcoma* - **Ewing's sarcoma** is a highly **malignant bone tumor** that is generally considered **radiosensitive** and often treated with radiation therapy. - Its cells are rapidly dividing, making them more vulnerable to the DNA-damaging effects of radiation. *GIT epithelium* - The **gastrointestinal tract (GIT) epithelium** is characterized by **rapid cell turnover** and high mitotic activity to constantly replace damaged cells and absorb nutrients. - This high proliferative rate makes the GIT epithelium highly **radiosensitive**, leading to common side effects like mucositis and diarrhea during radiation therapy. *Gonadal tumours* - Tumors of the **gonads** (e.g., testicular seminoma, ovarian dysgerminoma) are often highly **radiosensitive** and respond well to radiation therapy due to the germ cell origin and rapid proliferation of tumor cells. - The germ cells themselves are very sensitive to radiation, leading to concerns about **fertility preservation** in patients undergoing treatment.
Question 5: Which of the following is the platinum-based chemotherapeutic agent used as first-line treatment for ovarian carcinoma?
- A. Cyclophosphamide
- B. Methotrexate
- C. Cisplatin (Correct Answer)
- D. Dacarbazine
Explanation: ***Cisplatin*** - **Cisplatin** is a platinum-based chemotherapy drug that forms **DNA cross-links**, inhibiting DNA synthesis and leading to the death of rapidly dividing cells, making it highly effective against **ovarian carcinoma**. - It is a cornerstone of chemotherapy regimens for ovarian cancer, often used in combination with other agents such as paclitaxel. *Methotrexate* - **Methotrexate** is an **antimetabolite** that inhibits dihydrofolate reductase, thereby interfering with DNA synthesis. - While it is used in various cancers like leukemia, lymphoma, and some solid tumors (e.g., breast cancer, gestational trophoblastic disease), it is **not a primary recommended drug for ovarian carcinoma**. *Cyclophosphamide* - **Cyclophosphamide** is an **alkylating agent** that causes DNA damage, leading to cell death. - It is used in many cancers, including lymphoma, breast cancer, and some leukemias, but it is **not a first-line or primary agent for ovarian carcinoma** in contemporary treatment guidelines. *Dacarbazine* - **Dacarbazine** is an **alkylating agent** primarily used in the treatment of **malignant melanoma** and Hodgkin lymphoma. - It is **not indicated for the treatment of ovarian carcinoma**.
Question 6: International prognostic index for lymphomas includes the following prognostic factors, EXCEPT:
- A. LDH
- B. Number of extralymphatic sites involved
- C. Hemoglobin and albumin (Correct Answer)
- D. Stage of disease
Explanation: ***Hemoglobin and albumin*** - While hemoglobin and albumin can be indicators of overall health and nutritional status, they are **not part of the standard International Prognostic Index (IPI)** for lymphomas. - The IPI specifically focuses on factors directly related to tumor burden and patient vitality, not general systemic markers like these. *LDH* - **Lactate dehydrogenase (LDH)** is a crucial component of the IPI, reflecting tumor burden and aggressiveness [1]. - Elevated LDH levels indicate a higher risk and are associated with a poorer prognosis [1]. *Number of extralymphatic sites involved* - The **number of extralymphatic sites involved** is a key prognostic factor in the IPI. - Involvement of more than one extralymphatic site indicates more widespread disease and a worse prognosis. *Stage of disease* - The **stage of disease**, as defined by the Ann Arbor staging system, is an essential element of the IPI [1]. - Advanced stages (III or IV) are associated with a poorer prognosis compared to early stages [1].
Question 7: A 26-year-old male presents to the outpatient department with a discrete thyroid swelling. On neck ultrasound, an isolated cystic swelling of the gland is seen. What is the risk of malignancy associated with this finding?
- A. 48%
- B. 12%
- C. 24%
- D. 3% (Correct Answer)
Explanation: ***3%*** - **Purely cystic thyroid nodules** (as described in this case with "isolated cystic swelling") have a **very low risk of malignancy**, typically **2-3%** or less. - According to **ATA guidelines** and **TIRADS classification**, purely cystic nodules are considered **low suspicion** lesions. - The cystic nature suggests a **benign process** such as a degenerated adenoma, colloid cyst, or simple cyst. - **Fine needle aspiration (FNA)** may still be considered if the nodule is >2 cm or has any suspicious solid components, but is often not required for purely cystic lesions. *48%* - This percentage is **significantly higher** than the actual malignancy risk for a purely cystic thyroid swelling. - Such a **high risk** would typically be associated with **solid nodules** exhibiting highly suspicious ultrasound features such as: - Microcalcifications - Irregular or spiculated margins - Taller-than-wide shape - Marked hypoechogenicity - Extrathyroidal extension *24%* - This percentage represents a **moderate to high risk** of malignancy, which is **not characteristic** of an isolated purely cystic thyroid swelling. - A risk in this range might be seen with: - **Mixed solid-cystic nodules** with predominantly solid components - Solid nodules with **intermediate suspicious features** on ultrasound *12%* - While lower than 24% or 48%, 12% is still **considerably higher** than the generally accepted malignancy risk for purely cystic thyroid nodules. - This risk level could be plausible for: - **Predominantly cystic nodules** with some eccentric solid components - Solid nodules with **mildly suspicious** features on ultrasound
Question 8: What is the radiation tolerance of the whole liver?
- A. 30 Gy (Correct Answer)
- B. 45 Gy
- C. 15 Gy
- D. 40 Gy
Explanation: ***30 Gy*** - The **whole liver** has a relatively low radiation tolerance, with a typical threshold for developing **radiation-induced liver disease (RILD)** around 30-35 Gy for conventional fractionation. - Exceeding this dose to a significant volume of the liver can lead to **hepatic dysfunction** and failure. *45 Gy* - This dose is generally too high for whole-liver irradiation and would significantly increase the risk of **severe liver toxicity** in many patients. - While small volumes might tolerate higher doses, the **mean dose to the entire organ** should remain much lower. *15 Gy* - This dose is typically considered well below the tolerance limit for the whole liver and is unlikely to cause significant complications. - It might be used for palliation or as a component of fractionated regimens with higher doses to smaller target volumes. *40 Gy* - This dose is generally considered above the safe limits for irradiating the **entire liver**, posing a substantial risk of **radiation-induced liver damage**. - While some highly conformal techniques might deliver this to very small, localized tumors, it is not the tolerance for the **whole organ**.
Question 9: When is oxygen effective during radiotherapy?
- A. During and within microseconds of starting (Correct Answer)
- B. Just before starting the therapy
- C. After 5 minutes
- D. After 10 minutes
Explanation: ***During and within microseconds of starting*** - Oxygen is effective during radiotherapy primarily due to the **oxygen enhancement ratio (OER)**, which describes the increased radiosensitivity of cells in the presence of oxygen. - This effect is almost instantaneous, as oxygen acts as a **radical sensitizer** by stabilizing DNA damage caused by radiation, making it irreparable by cellular repair mechanisms. *Just before starting the therapy* - While having oxygen present just before therapy is important, the actual sensitization effect requires oxygen to be present **during** the radiation exposure itself. - Simply having oxygen before without its presence during treatment will not maximize the therapeutic benefit. *After 5 minutes* - The critical period for oxygen's radiosensitizing effect is during and immediately after the ionization events caused by radiation, which occur over **microseconds**. - Oxygen administered 5 minutes after radiation exposure would be too late to impact the initial damage fixation process. *After 10 minutes* - Similar to the 5-minute mark, oxygen delivered 10 minutes after radiation would have **no significant impact** on the immediate radiation-induced cellular damage. - The window of opportunity for oxygen to enhance radiosensitivity is extremely short, occurring at the moment of radiation interaction with biological molecules.
Question 10: A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following statements about radiation therapy is true?
- A. Small intestinal mucosa is radioresistant.
- B. Rapidly proliferating cells are radioresistant.
- C. Intensity is inversely proportional to the square of the distance from the source. (Correct Answer)
- D. Small blood vessels are radioresistant.
Explanation: ***Intensity is inversely proportional to the square of the distance from the source.*** - This statement accurately describes the **inverse square law**, a fundamental principle in radiation physics, meaning radiation intensity decreases rapidly as the distance from the source increases. - This principle is crucial in **radiotherapy planning** to ensure precise dose delivery to the tumor while minimizing exposure to surrounding healthy tissues. *Small blood vessels are radioresistant.* - **Small blood vessels** (capillaries and arterioles) are actually **radiosensitive** and are often damaged by radiation, leading to late effects such as fibrosis and atrophy. - Damage to the vascular endothelium can cause **vascular insufficiency**, contributing to long-term tissue damage in irradiated areas. *Rapidly proliferating cells are radioresistant.* - Cells that are **rapidly proliferating** (have a high mitotic rate) are generally **radiosensitive**, making them more susceptible to radiation-induced damage. - This is the basis for using radiation therapy to target fast-growing cancers, as the radiation effectively destroys cells during their division phase. *Small intestinal mucosa is radioresistant.* - The **small intestinal mucosa** is composed of rapidly dividing cells and is therefore among the **most radiosensitive tissues** in the body. - This radiosensitivity often leads to common side effects of abdominal and pelvic radiotherapy, such as **nausea, vomiting, and diarrhea**.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free